Brian Lawrence

Dr. Lawrence is Founder CEO of SilkTech Biopharmaceuticals, and has over 15 years’ experience in developing silk-based materials for use in medical and commercial product applications. Previously he was CEO of both Bombyx Technologies and Seryx Biomedical, both were previous medical device startups in ophthalmology, and worked as an engineer in the biotechnology and chemical manufacturing sectors before becoming an entrepreneur. Dr. Lawrence is a recognized leader in the silk material development space, and has numerous publications and issued patents related to silk-based technologies. He earned his PhD in Biomedical Engineering from Cornell University, an MS from Tufts University, and a BSE from University of Toledo.